Form 4 for DMRA Damora Therapeutics, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001193125-26-006723 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-07 | 2026-01-05 | DMRA | Hewes L. Becker | Chief Medical Off | A - Grant | $0.00 | +264.6K | 264.6K | New | $0 |
| D | 2026-01-07 | 2026-01-05 | DMRA | Hewes L. Becker | Chief Medical Off | A - Grant | $0.00 | +528.6K | 528.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | A | A | 264,629 | $0.00 | 264,629 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the right to receive, at settlement, one share of common stock of the Issuer. The RSUs will vest with respect to 25% on each anniversary of the grant date through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2026-01-05 | A | A | 528,603 | $0.00 | 528,603 | D | $21.82 · — to 2036-01-05 | 528,603 Common Stock | (F2) This option represents a right to purchase shares of common stock of the Issuer. This option will vest as to 25% on January 5, 2027 and in equal monthly installments thereafter through January 5, 2030, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |